Graphene emerges as a versatile new surface to assemble model cell membranes mimicking those in the human body, with potential for applications in sensors for understanding biological processes, disease detection and drug screening.
Writing in Nature Communications, researchers at The University of Manchester led by Dr Aravind Vijayaraghavan, and Dr Michael Hirtz at the Karlsruhe Institute of Technology (KIT), have demonstrated that membranes can be directly ‘written’ on to a graphene surface using a technique known as Lipid Dip-Pen Nanolithography (L-DPN).
The human body contains 100 trillion cells, each of which is enveloped in a cell membrane which is essentially a phospholipid bi-layer membrane. These cell membranes have a plethora of proteins, ion channels and other molecules embedded in them, each performing vital functions.
It is essential, therefore, to study and understand these systems, thereby enabling their application in areas such as bio-sensing, bio-catalysis and drug-delivery. Considering that it is difficult to accomplish this by studying live cells inside the human body, scientists have developed model cell membranes on surfaces outside the body, to study the systems and processes under more convenient and accessible conditions.
Dr Vijayaraghavan’s team at Manchester and their collaborators at KIT have shown that graphene is an exciting new surface on which to assemble these model membranes, and brings many advantages compared to existing surfaces.
Dr Vijayaraghavan said: “Firstly, the lipids spread uniformly on graphene to form high-quality membranes. Graphene has unique electronic properties; it is a semi-metal with tuneable conductivity.
“When the lipids contain binding sites such as the enzyme called biotin, we show that it actively binds with a protein called streptavidin. Also, when we use charged lipids, there is charge transfer from the lipids into graphene which changes the doping level in graphene. All of these together can be exploited to produce new types of graphene/lipids based bio-sensors.”
The Latest on: Biosensors
- Health: UBI has more cash than its market capon January 23, 2020 at 3:54 pm
had an up quarter in December, with cash flow turning positive. The ... Read More The post Health: UBI has more cash than its market cap appeared first on Stockhead.
- Wearable Biosensors Market 2020 Analysis, Growth, Vendors, Shares, Drivers, Challenges with Forecast to 2025on January 22, 2020 at 11:43 pm
New York, January 23, 2020: A wearable biosensor is an analytical device which is used to monitor vital signs of an individual person. It consists of three major components including bioreactor system ...
- Low Cost Graphene Biosensors on Plasticon January 22, 2020 at 11:39 pm
In industries such as aerospace, wearables, building materials and life sciences, two-dimensional ‘monolayer’ materials are gaining growing acceptance as advanced sensor substrates. In particular, ...
- Biosensors, data privacy and manufacturing research highlighted at Davoson January 22, 2020 at 9:39 am
Research into biosensors, data privacy and advanced manufacturing was highlighted at the World Economic Forum in Davos by Imperial academics. The academics joined world leaders from the G20 and other ...
- Ruslan Dmitriev on FLIM and intestinal organoidson January 22, 2020 at 5:37 am
My research is centered around developing new high-performance biosensors, which enable you to do fluorescence lifetime imaging of various cellular processes such as metabolism, dynamics of lipid ...
via Google News and Bing News